To access this element change to forms mode OFF
Grant Award View - GA79773
High throughput discovery of synergistic drug combinations for patients...
GA ID:
GA79773
Agency:
Department of Health and Aged Care
Approval Date:
5-May-2020
Publish Date:
26-May-2020
Category:
Health and Medical Research
Grant Term:
1-Jun-2020 to 31-May-2024
Value (AUD):
$1,109,189.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 19/20 1.1 Health Policy Research and Analysis
Grant Program:
2019_MRFF_EPCDR_Ovarian_Cancer_2020
Grant Activity:
High throughput discovery of synergistic drug combinations for patients with low-grade serous ovarian cancer
Purpose:
Little is known about the best treatment strategies for women with low-grade serous ovarian cancers. We will systematically investigate novel drug combinations with a study of the key genetic determinants of response to these combinations in a large panel of patient-derived tumour cells. This innovative project is the first of its kind, and will highlight new treatment opportunities, and create immediate clinical drug development opportunities to significantly improve patient outcomes.
GO ID:
GO Title:
MRFF – EPCDR Initiative – 2019 Ovarian Cancer Research Grant Opportunity
Internal Reference ID:
MRF1200264
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA